Macrogen, Inc. (KOSDAQ:038290)

South Korea flag South Korea · Delayed Price · Currency is KRW
15,770
+50 (0.32%)
Jun 2, 2025, 3:30 PM KST
-21.15%
Market Cap 170.97B
Revenue (ttm) 145.10B
Net Income (ttm) -7.67B
Shares Out 10.84M
EPS (ttm) -751.53
PE Ratio n/a
Forward PE 22.21
Dividend 300.00 (1.90%)
Ex-Dividend Date Dec 27, 2024
Volume 9,793
Average Volume 9,916
Open 15,650
Previous Close 15,720
Day's Range 15,630 - 15,900
52-Week Range 14,700 - 24,600
Beta 0.72
RSI 51.67
Earnings Date May 15, 2025

About Macrogen

Macrogen, Inc. provides precision medicine and bio-engineering healthcare services in Korea and internationally. It offers personal healthcare services, including disease prediction and wellness genetic, and DTC genetic testing services; MyPETGENE, a genetic testing service for companion animals; clinical services, such as precision medicine, genetic testing for cancer risk, NGS-based genetic panel lab, and GCLP services; and single cell expert services comprising single cell multi-omics and spatial transcriptome analysis, and single cell (In S... [Read more]

Industry Commercial Physical and Biological Research
Founded 1997
Employees 500
Stock Exchange KOSDAQ
Ticker Symbol 038290
Full Company Profile

Financial Performance

In 2024, Macrogen's revenue was 135.78 billion, an increase of 2.24% compared to the previous year's 132.80 billion. Losses were -7.60 billion, -54.78% less than in 2023.

Financial Statements

News

There is no news available yet.